Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update on enhanced external counterpulsation.

Michael L Shea1, C Richard Conti, Rohit R Arora

  • 1Division of Cardiovascular Disease and Hypertension, Department of Medicine, Robert Wood Johnson Medical School-UMDNJ, New Brunswick, New Jersey 08903-0019, USA.

Clinical Cardiology
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Dioxin and Dioxin-like Congeners With Hypertension.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2019
Same author

Obesity and Weight Loss.

European cardiology·2019
Same author

Cryptogenic Stroke: To Close a Patent Foramen Ovale or Not to Close?

Journal of central nervous system disease·2018
Same author

The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.

Journal of cardiovascular pharmacology and therapeutics·2018
Same author

Non-PCI/CABG therapies for refractory angina.

Trends in cardiovascular medicine·2017
Same author

The Need for Extracorporeal Membrane Oxygenation in Adults Undergoing Congenital Heart Surgery: Impact and Trends of Utilization.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2017
Same journal

In-Hospital Cardiac Arrest Detection Performance Analysis and Comparison on Effective Feature Selection.

Clinical cardiology·2026
Same journal

Interpreting the Association Between Diuretic Intensity Score and Mortality: The Potential Roles of Diuretic Responsiveness and Mineralocorticoid Receptor Antagonist Therapy.

Clinical cardiology·2026
Same journal

Heart Failure With Preserved Ejection Fraction-Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA Cohort.

Clinical cardiology·2026
Same journal

Ethanol Infusion Into the Vein of Marshall for Atrial Fibrillation: Clinical Efficacy and Technical Limitations.

Clinical cardiology·2026
Same journal

Methodological Considerations Regarding Diuretic Intensity Score and Mortality in Hospitalized Heart Failure Patients.

Clinical cardiology·2026
Same journal

Inpatient Outcomes and Complications After Left Atrial Appendage Occlusion in Rural Versus Urban Hospitals in the United States.

Clinical cardiology·2026
See all related articles

Enhanced external counterpulsation (EECP) offers a safe and effective treatment for chronic refractory angina in nonrevascularizable coronary artery disease patients. This therapy improves angina symptoms, exercise capacity, and quality of life, even in those with heart failure.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Medical Devices

Background:

  • Advanced revascularization techniques have led to a growing population of patients with coronary artery disease (CAD) who are nonrevascularizable.
  • These patients often suffer from chronic, refractory angina, significantly impacting their quality of life.
  • Existing treatments may be insufficient for this challenging patient subset.

Purpose of the Study:

  • To evaluate the efficacy and safety of Enhanced External Counterpulsation (EECP) in managing patients with chronic, refractory angina.
  • To explore the mechanisms by which EECP confers clinical benefits in this population.
  • To assess the potential of EECP in patients with comorbid conditions like impaired systolic function and congestive heart failure.

Main Methods:

Related Experiment Videos

  • The study focuses on the application of Enhanced External Counterpulsation (EECP) as a therapeutic modality.
  • Evidence suggests EECP improves vascular endothelial function.
  • EECP is also shown to promote the recruitment of collateral vessels.

    • Main Results:

    • Patients treated with EECP experience sustained decreases in angina symptoms.
    • Significant improvements in exercise tolerance and time have been observed.
    • Enhanced myocardial perfusion and improved quality of life are key outcomes.
    • EECP demonstrates safety and effectiveness in patients with impaired systolic function.
    • The therapy shows potential benefits for patients with congestive heart failure.

    Conclusions:

    • Enhanced External Counterpulsation (EECP) is a safe and effective treatment option for patients with nonrevascularizable coronary artery disease and refractory angina.
    • EECP offers significant clinical benefits, including symptom relief, improved exercise capacity, and enhanced quality of life.
    • The therapeutic potential of EECP extends to patients with impaired systolic function and congestive heart failure, warranting further investigation.